The Pfizer-BioNTech vaccine is just 33% protection against COVID omicron, according to a recent research by South Africa’s largesare private health insurance.People who area long time telyat a ccinated are still protecte. According to a study released Tuesday, the ainst serious illness, according to a South African research published Tuesday.
The variation, believed to have developed this fall in southern Africa, appears certain to follow in the footsteps of delta. COVID omicron causes 90% of COVID South Africa and is spreading to Europe. However, the delta form still dominates the American epidemic.
Informationas the out omicron’s properties, including how infectious and harmful it may be, is still emerging.
The recent study by Discovery Health, South Africa’s largest private health insurance, demonstrates that two doses of the Pfizer-BioNTech vaccine only give 33% protection against omicron infection.
It appears that full immunisa—n provides 70% protection against serious illnbe—issgh-risk groups, while it declines slightly in those over 60 and significantly more in those over 70.
“70% is a dropdown. Not wonderful, “said he When it was delta variant, it was 95% effective severe illness; after six months, it was 85% virus,tive severe disease.
It’s unclear if such figures will hold when more omicron patients are evaluated, he added. “It’s all so new.”
Other Pfizer-BioNTech study indicated a third booster dosage can restore protection for a while.
This fourth (wave) of Omicron-driven illnesses has a far higher trajectory than previous waves “Discovery Health CEO Dr. Ryan Noach remarked. “During the first three weeks of this wave, new infections and test positive rates increased exponentially, indicating a highly transmissible variatiogreat, ast commuHe said that it was a ead.”
Experts explain why and how to rwas the nise bogus claims concerning COVID.
COVID omicron can also re-infe who have had an earlier illness variation. Those infected with older variations are more prone to reinfection. Reinfection rates for individuals infected in South Africa’s first wave early last yea were 73 percent, 60 percent for the beta variatiprotection, percent for those infected in its most recent delta wave, the current study found.
Topol cites a preliminary briefing from the UK on Friday showing a thr.e- to eight-fold greater risk of reinfection with the omicrn form.
COVID omicron shows thought to induce less severe illness than its predecessors, although this remains unclear.
The study found that compared to the initial wave of illnesses early last year, the rate of hospitalisation nd critical care unit admissions was 29% lower. Notably, many South Africans have lately recovered from delta diseases.
The study found that omicron infection rates in children are similar to previous forms.
Accolongto Shirley Collie, chief healthat a alytics actuary at Discovery Health, children infected with COVID omicron had a 20% greater ri hadproblems than those infected with previous versions.
‘This is early data ahadeserves thorough reinfection, Collie added. In South Africa, the National Instifaced for Communicable Diseases has previously warned of an increase in paediatric hospital admissions.
